Results 151 to 160 of about 19,990 (188)
Some of the next articles are maybe not open access.
Journal of Antimicrobial Chemotherapy
Abstract Background Use of anti-carbapenem-resistant Enterobacterales (anti-CRE) agents such as ceftazidime/avibactam has been associated with improved clinical outcome in cohorts that primarily include patients infected with CRE that are resistant to meropenem (MCRE).
Gregory Weston +15 more
openaire +2 more sources
Abstract Background Use of anti-carbapenem-resistant Enterobacterales (anti-CRE) agents such as ceftazidime/avibactam has been associated with improved clinical outcome in cohorts that primarily include patients infected with CRE that are resistant to meropenem (MCRE).
Gregory Weston +15 more
openaire +2 more sources
Carbapenemase-Producing Enterobacterales in Algeria: A Systematic Review
Microbial Drug Resistance, 2020The dramatic increase in prevalence and clinical impact of infections caused by carbapenemase-producing Enterobacterales (CPE) are major and ongoing public health problems globally. The carbapenemase groups most commonly encountered include Klebsiella pneumoniae carbapenemase (KPC), New Delhi
Abdelaziz, Touati, Assia, Mairi
openaire +2 more sources
Molecular Mechanisms of Tigecycline-Resistance Among Enterobacterales
Frontiers in Cellular and Infection MicrobiologyThe global emergence of antimicrobial resistance to multiple antibiotics has recently become a significant concern. Gram-negative bacteria, known for their ability to acquire mobile genetic elements such as plasmids, represent one of the most hazardous microorganisms. This phenomenon poses a serious threat to public health. Notably, the significance of
Piotr Wieczorek +2 more
exaly +4 more sources
Resistencia a colistina en enterobacterales
2022ABSTRACT Antimicrobial resistance currently represents one of the main public health problems worldwide. In our country, most nosocomial infections are caused by germs resistant to multiple antimicrobials. This situation has meant that in recent years colistin has been used for their treatment, the use of which has been limited for many years due to ...
openaire +1 more source
Carbapenem-resistant Enterobacterales in the USA
The Lancet Infectious Diseases, 2020Sumanth, Gandra, Carey-Ann D, Burnham
openaire +2 more sources
Carbapenem-resistant Enterobacterales (CRE): The storm is coming
Intensive and Critical Care Nursing, 2023Zahar, Jean-Ralph, Blot, Stijn
openaire +4 more sources
Detection of carbapenemases in Enterobacterales susceptible in vitro to meropenem
Enfermedades Infecciosas y Microbiología ClínicaCarbapenemase-producing Enterobacterales (CPE) is a global threat. We evaluate the prevalence of CPE among isolates categorized as meropenem-susceptible, but that meet the European Committee on Antimicrobial Susceptibility Testing (EUCAST) screening cut-off values for carbapenemase detection, and analyze the susceptibility of these isolates to new ...
Luana Silva, Dornelles +5 more
openaire +2 more sources
[Multi-resistant Enterobacterales and travel].
Revue medicale suisseMulti-resistant Enterobacterales (MRE) are on the increase worldwide, with the main mechanism of resistance acquisition being horizontal transfer of plasmids coding for extended-spectrum betalactamase and/or carbapenemase. Low- and middle-income countries are the most affected, but surveillance in low-endemicity countries, such as Switzerland, is ...
Kourosh, Massiha +2 more
openaire +1 more source
Carriage and infections by multi-carbapenemases producing Enterobacterales
Diagnostic Microbiology and Infectious DiseaseMulti-carbapenemases producing Enterobacterales (MCP-EB) represents a new public health challenge due to their ability to display complex resistance phenotypes.MCP-EB isolates identified from patients admitted to an Italian Center in the period 2020-2024 were included.
Matteo Boattini +3 more
openaire +2 more sources